Anti-microRNA-19
N/A
Report date: 2022/01/24 09:15:42
NME
Base Information
Drug NameAnti-microRNA-19
Drug Alias Name +[8]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAstrazeneca PlcRegulus Therapeutics
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesRegulus TherapeuticsAstrazeneca Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A